ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 678,19
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,105
-0,63%
Bitcoin
61 885,79
4,68%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ReShape Lifesciences Inc (RSLS)

  7. ReShape Lifesciences Inc (RSLS) Actualités

RSLS ReShape Lifesciences Inc

0,1724
-0,0029 (-1,65%)
Dernière mise à jour : 19:17:17
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ReShape Lifesciences Inc RSLS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0029 -1,65% 0,1724 19:17:17
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,175 0,1687 0,179 0,1753
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202422:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
28/3/202413:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
04/3/202414:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
26/2/202422:19EDGAR2Form 8-K - Current report
22/2/202414:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
24/1/202414:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
18/1/202422:38EDGAR2Form 8-K - Current report
17/1/202400:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202422:14EDGAR2Form PRE 14A - Other preliminary proxy statements
20/12/202314:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
12/12/202322:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
29/11/202322:05EDGAR2Form 8-K - Current report
21/11/202314:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
08/11/202322:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
06/11/202314:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
13/10/202322:42EDGAR2Form 8-K - Current report
05/10/202322:05EDGAR2Form 8-K - Current report
03/10/202315:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/9/202318:30GLOBEReShape Lifesciences® Announces Pricing of $3.0 Million..
27/9/202323:30EDGAR2Form S-1/A - General form for registration of securities..
22/9/202322:02EDGAR2Form 8-K - Current report
22/9/202314:31GLOBEReShape Lifesciences® Announces Participation in the LD..
21/9/202314:31GLOBEReShape Lifesciences® Signs Exclusive License Agreement With..
19/9/202314:31GLOBEReShape Lifesciences® Significantly Strengthens Patent..
14/9/202314:31GLOBEReShape Lifesciences® Receives NIH SBIR Grant to Further..
25/8/202322:41EDGAR2Form S-1 - General form for registration of securities under..
07/8/202323:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:54EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
03/8/202322:05GLOBEReShape Lifesciences® to Announce Financial Results for the..
29/6/202314:31GLOBEReShape Lifesciences® Signs Preferred Partner Agreement With..
28/6/202314:31GLOBEReShape Lifesciences® Presents Data on its Proprietary..
26/6/202322:05GLOBEReShape Lifesciences® Submits FDA PMA Supplement Application..
23/6/202314:35GLOBELife Science Investor Forum: Presentations Now Available for..
20/6/202316:58GLOBELife Science Investor Forum Agenda Announced for June 22nd
14/6/202314:31GLOBEReShape Lifesciences® to Participate in Investor and..
15/5/202322:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
11/5/202314:30GLOBEReShape Lifesciences® to Announce Financial Results for the..

Dernières Valeurs Consultées

NASDAQ
RSLS
ReShape Lifesciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés